Current Pharmacologic Options and Emerging Therapeutic Approaches for the Management of Ulcerative Colitis: A Narrative Review
Open Access
- 9 September 2024
- journal article
- review article
- Published by Michigan State University College of Osteopathic Medicine Graduate Medical Education Alliance in Spartan Medical Research Journal
- Vol. 9 (3) , 123397
Abstract
Introduction: Ulcerative colitis (UC) is a chronic inflammatory bowel disorder (IBD) with periods of relapse and remission. Current advancements in clinical research have led to the development of more refined and effective medical therapy for UC. Summary of the Evidence: Traditional therapeutic agents such as 5-aminosalicylates (5-ASAs), sulfasalazine (SASP), corticosteroids, and immunomodulatory drugs have remained the gold standard for decades. However, their novel formulations and dosage regimens have changed their sequences in the medical management of UC. Several other novel drugs are in the final phases of clinical development or have recently received regulatory approval designed to target specific mechanisms involved in the inflammatory cascade for UC. Conclusions: This narrative review sought to provide a comprehensive knowledge of the potential benefits of standard and emerging therapies, including novel formulations, new chemical entities, and novel therapeutic approaches in managing UC. Keywords: Ulcerative colitis, 5- Aminosalicylic acid, sulfasalazine, corticosteroids, biologics, immunomodulators, novel formulationsKeywords
This publication has 54 references indexed in Scilit:
- Mesalamine in the Initial Therapy of Ulcerative ColitisGastroenterology Clinics of North America, 2020
- Assessing Severity of Disease in Patients with Ulcerative ColitisGastroenterology Clinics of North America, 2020
- Efficacy of apheresis as maintenance therapy for patients with ulcerative colitis in an open-label prospective multicenter randomised controlled trialJournal of Gastroenterology, 2019
- Endoscopic scoring indices for evaluation of disease activity in ulcerative colitisCochrane Database of Systematic Reviews, 2018
- Ulcerative Colitis: What is the Optimal Treatment Goal and How Do We Achieve It?Current Treatment Options in Gastroenterology, 2015
- Ulcerative ColitisMayo Clinic Proceedings, 2014
- Efficacy and safety of mesalamine suppositories for treatment of ulcerative proctitis in children and adolescentsInflammatory Bowel Diseases, 2010
- Treatment of Immune-Mediated Extraintestinal Manifestations of Inflammatory Bowel Disease with InfliximabGastroenterology Clinics of North America, 2006
- Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis2003
- Long-term use of mesalamine enemas to induce remission in ulcerative colitisGastroenterology, 1990